Intellia Therapeutics Inc. (NTLA) is one of the largest holdings in the iShares Russell 2000 exchange-traded fund (IWM) and one Real Money subscriber wonders if this stock can help the IWM break out of its long, sideways trading range. The company is a pioneer in the development of CRISPR/Cas9 genome editing.
More from Investing
Here's what's keeping the rally running, even if trading is becoming volatile and inconsistent.
Simply put, this one checks all my technical boxes, including price.
I'm not going to make a move in front of earnings, but if the company executes well on this, it's going to be huge for them.
These names are among our favorite Dividend Achievers, those companies with at least a decade of dividend growth.